Physician profile
Brian S Grossman
NPI 1518996859
$415,321.07
in general payments reported to CMS, 2019-2025
22 companies · $434 in 2025
The $434 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,963 · 2020: $299 · 2021: $350 · 2022: $383K · 2023: $29K · 2024: $18.73 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $29K · Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $29,371.85 |
| Food and Beverage | $452.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $411,825.37 | 2022-2023 | Fibulink |
| Medacta USA, INC. | $1,269.25 | 2019 | |
| Globus Medical, INC. | $402.79 | 2022 | |
| Nexxt Spine LLC | $398.19 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $244.70 | 2019-2020 | |
| Nevro Corp. | $162.61 | 2021 | |
| Highridge Medical LLC | $141.24 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $141.24 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ulrich Medical USA, INC. | $125.00 | 2019 | |
| Misonix INC | $121.50 | 2019 | |
| Alphatec Spine, INC | $118.45 | 2021 | |
| Ethicon US, LLC | $114.80 | 2025 | Surgiflo Hemostatic Matrix, Stratafix, Vistaseal |
| Depuy Synthes Sales INC. | $51.96 | 2021 | |
| Nalu Medical, INC. | $36.52 | 2025 | Nalu Neurostimulation System |
| 4web, INC. | $30.03 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gs Solutions, INC. | $28.74 | 2022 | |
| Horizon Therapeutics Plc | $27.38 | 2019 | |
| Centinel Spine, LLC | $24.08 | 2020 | |
| Nuvasive, INC. | $21.64 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.73 | 2024 | Iovera, Zilretta, Exparel |
| Kyocera Medical Technologies, INC. | $16.85 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$450,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.